IMPAIRED PRODUCTION OF IL-12 IN SYSTEM LUPUS-ERYTHEMATOSUS - II - IL-12 PRODUCTION IN-VITRO IS CORRELATED NEGATIVELY WITH SERUM IL-10, POSITIVELY WITH SERUM IFN-GAMMA AND NEGATIVELY WITH DISEASE-ACTIVITY IN SLE
Tf. Liu et Bm. Jones, IMPAIRED PRODUCTION OF IL-12 IN SYSTEM LUPUS-ERYTHEMATOSUS - II - IL-12 PRODUCTION IN-VITRO IS CORRELATED NEGATIVELY WITH SERUM IL-10, POSITIVELY WITH SERUM IFN-GAMMA AND NEGATIVELY WITH DISEASE-ACTIVITY IN SLE, Cytokine, 10(2), 1998, pp. 148-153
Interleukin 12 (IL-12) is a key cytokine in regulating type 1 or type
2 cytokine production and in determining the nature of immune response
s. Our previous studies demonstrated that its production was significa
ntly impaired in systemic lupus erythematosus (SLE) patients and this
deficient IL-12 production was mainly mediated by excessive endogenous
IL-10. The present study was designed to further reveal the relations
hips of in vitro IL-12 production with abnormalities of in vivo cytoki
ne synthesis and disease activity in SLE. Experimental results showed
that IL-12 production in vitro was inversely correlated with serum IL-
10 level, anti-ds DNA antibody level and SLE disease activity index (D
AI), but positively correlated with serum interferon gamma (IFN-gamma)
level, with which serum IL-10 correlated negatively, Data also showed
that serum IL-10 was significantly higher than that of controls and c
losely correlated with anti-ds DNA antibody level and SLEDAI. The stud
y confirms that deficient IL-12 production in SLE patients is associat
ed with in vivo abnormalities of cytokine production, especially with
increased IL-10 production. (C) 1998 Academic Press Limited.